Results
Indo US Bio-Tech Q2 FY27 Net Loss ₹3.67 Crore
• Board approved unaudited Q2 September 2026 financial results showing a net loss of ₹3.67 crore.
• Revenue from operations declined to ₹15.05 crore in Q2 from ₹30.85 crore in the year-ago quarter.
•